About our project

The problem we solve: Behavioral health is a global chronic health issue that impacts many health conditions. According to the WHO, stress, anxiety and depression are major problems in + 60 countries. In the U.S. 18% of adults have a mental, behavioral, or emotional disorder. 40MM Americans suffer from stress, anxiety and depression. The clinical environment lacks the necessary resources to provide effective treatment. Per Milliman +$525B is spent on costs directly associated with behavioral health. For payers, we help manage risk by scaling access to a mental health tool that improves clinical outcomes at lower costs by longitudinally engaging patients in self-care. For health systems, we also can identify high-risk individuals and provide care documentation capabilities which easily integrate into current their workflow and help them meet requirements of outcomes-based contracts. For pharma we are an adjunct digital therapeutic used to improve adherence and compliance.

About our solution: Recognized as international healthcare leaders by organizations such as the U.S. State Department, Litesprite is a game platform that helps patients manage and mitigate the effects of behavioral health, cancer, and diabetes. Clinicians rely on our data to help their patients achieve better results. Our clinically validated mental health videogame Sinaprite has validated reimbursement in 4 care-settings and an economic impact of 17 QALY/1000 patients. Sinasprite uses evidence-based treatment methods, including CBT-based and mindfulness strategies, to help people manage stress, anxiety, and depression. We are the only videogame used by payers and clinicians today. Bayer Pharmaceuticals is our most recent investor and partner. We have won +20 global health innovation awards including the first videogame to receive a U.S. Surgeon General Award and Puget Sound Business Journal’s Innovators of the Year.

Progress to date:

Key traction includes:

1. Independent clinical validation with our JMIR paper of our mental health video game Sinasprite. Read about it in MedCityNews and Geekwire.

2. The University of Washington Primary Care Innovation Lab Economic Impact Study projects Sinasprite’s clinical results has an economic impact of $1MM or 17 QALY/1000 patients. 

3. Investment & strategic partnership with Bayer (You can read more about this exciting partnership in VentureBeat, MobiHealthNews or Geekwire), SinfoniaRx, and Jumpstart Foundry.

4. With minimal sales optimization:

• Revenue realized.
• Robust sales pipeline.
• Receiving an increasing number of inbound requests from pharma, payers, and providers.

5. Validated CPT code reimbursement for 4 care-delivery settings: primary care, outpatient, partial hospital, and inpatient.

6. Strong user trust & affinity- our +1600 patients use Sinasprite, episodically and as a coping tool during key crisis moments throughout the years. We routinely find that we are a trusted support tool and have the greatest utility by those patients with the most complex cases – whether it’s mental, general, or cardiac health.

“I recently began using the program more regularly after a long break [1 year] and found it surprisingly helpful, even more so now than [before].” – M, 32.

7. +20 global health innovation awards including Puget Sound Business Journal’s Innovators of the Year.

Since COVID-19, the Puget Sound Business Journal has recognized that we "stepped forward to reimagine how we support each other through a crisis." We are included in CredibleMind, NYCWell, an initiative led by the First Lady of NYC, and several state COVID-19 resource lists.

Since March 10, 2020, our usage is skyrocketing. +439 individuals have organically downloaded Sinasprite and 2 clinics started using our clinical monitoring solutions) and weekly active users and sessions is up 3-4X. We help individuals and frontline providers with their anxiety, depression, and impacts of isolation

About Our Company

How We Help Patients

“It gives patients time to focus on themselves, they enjoy it, and on the backend - the reports are showing benefits. It’s a cool concept – a game with benefits.” Anne Begody, Director of Care Coordination, Assurance Health. We help individuals of all ages, caregivers, and frontline providers with their anxiety, depression, and impacts of isolation by giving them easy access to important mental health tools whose clinical efficacy have been independently validated. Sinasprite offers an experiential vs. instructional format that addresses the patient’s emotional needs. Our experience helps the player focus on their own issues and work through them at a self-directed pace while teaching them critical coping skills. Throughout the years, Sinasprite has been used episodically and is a coping tool during crisis moments. We have the greatest utility by those patients, including the underserved, with the most complex cases - whether it is mental, cardiac or general health.

How We Help Physicians

“I prescribe this app to my patients.” Dr. Douglas Maurer, Program Director, Faculty Development Fellowship, Madigan Army Medical Center. Our independently clinically validated mental health video-game Sinasprite is the first to win a U.S. Surgeon General Award for our work with the military and the only one recommended by payers and providers today. Clinicians rely on our data to remotely monitor patients, identify high-risk patients, and receive reimbursement. We have worked with individuals diagnosed with anxiety, depression, substance abuse, bipolar, and severe mental illness. Per the economic analysis conducted by the University of Washington's Primary Care Innovation Lab, the estimated range of net revenue for clinics with 1000 patients on their panel is $19,526.78 to $23,556.78 per year to manage depression via Sinasprite and $2,073.69 to $2,501.67 per year for anxiety. Our self-help tools have the optional involvement of the clinician. As our product only requires a smartphone, Sinasprite can be immediately be played by many patients and their results be easily assessed by the clinical staff. This ease and immediate access to our tool plays a critical role in improving staffing efficiency.

How We Help Hospitals

“This is great data! I agree it is very encouraging ;) I will share this with the rest of our management team.” Catherine Stacey, Chief Clinical Officer, Assurance Health & Wellness. Our independently clinically validated mental health video-game Sinasprite is the first to win a U.S. Surgeon General Award for our work with the military and the only one recommended by payers and providers today. We have worked with individuals diagnosed with anxiety, depression, substance abuse, bipolar, and severe mental illness. For health systems, we can remotely monitor patients, identify high-risk individuals, provide reimbursement, and care documentation capabilities which easily integrate into current their workflow and help them meet requirements of outcomes-based contracts. With those health systems in competitive markets, our patient experiences provides differentiation and patient loyalty. Per the economic analysis conducted by the University of Washington's Primary Care Innovation Lab, the estimated range of net revenue for clinics with 1000 patients on their panel is $19,526.78 to $23,556.78 per year to manage depression via Sinasprite and $2,073.69 to $2,501.67 per year for anxiety. Our self-help tools have the optional involvement of the clinician. As our product only requires a smartphone, Sinasprite can be immediately be played by many patients and their results be easily assessed by the clinical staff. This ease and immediate access to our tool plays a critical role in improving staffing efficiency.

How We Help Partners

We’ve established mutually supportive global relationships where we inspire and accelerate the success of our colleagues and partners. With our pharma partners, such as Bayer, we are an adjunct digital therapeutic used to improve adherence and compliance. For our health plan partners, we help manage risk by scaling access to a mental health tool that improves clinical outcomes at lower costs by longitudinally engaging patients in self-care. We help them deploy new care models and strengthen their existing relationships with their provider groups. With those health plans in competitive markets, our patient experiences also provide differentiation and member loyalty. By interacting with us, our partner organizations have also gained new insights that made them think differently about commercializing innovations and the populations they serve.

Challenge Mission

Innovation Details

Intellectual Property Summary

Similar to other software products and games, our tacit and subject matter expertise has been built into our product. This has translated into longitudinal engagement.

Clinical Information

1. Independent clinical validation with our JMIR paper of our mental health video game Sinasprite. Read about it in MedCityNews and Geekwire.

2. U.S. Army Study results were presented the North American Primary Care Research Group's Annual Meeting and resulted in a U.S. Surgeon Finanical Award.

3. The University of Washington Primary Care Innovation Lab Economic Impact Study projects Sinasprite’s clinical results has an economic impact of $1MM or 17 QALY/1000 patients. 

4. Our clinical results have been presented at Stanford Medicine X, Health Plan Association, American Psychiatric Association's Annual Meeting (’17, ’18), Academy of Managed Care Pharmacy's Annual Meeting, SXSW (’15,’18), and Singularity University.

Regulatory Status

Per FDA guidance we have received to date and the consistent general guidance that has been issued, we are not considered a medical device and are exempt from requiring approval. However we do intend to apply for FDA approval as a digital therapeutic. The pathway would be similar to how Welldoc (the first moble health app to receive FDA clearance) treaded on their course to FDA clearance.

How we will use the funds raised

The funding will cover operational costs so we can continue to respond to the COVID-19 outbreak and provide complimentary access to essential mental health tools and services internationally. We made Sinasprite and our clinical remote patient monitoring solutions free to individuals, healthcare providers, and health plans.

Funding will further our product development, sales and marketing activities, and staffing. Within product development, we can enhance our patient montioring capabilities, begin to build our predictive analytics alogrithms, and develop digital biomarkers. Funding would also allow us to meet product demand from a new customer base. We are being contacted by employers whose employees are reporting significant increase of anxiety due to isolation and personal responsibilities.

Thank You

We have changed people’s lives – including the underserved. With COVID-19, we help individuals and frontline providers with their anxiety, depression, and impacts of isolation. They regularly trust, enjoy, and use our accessible independently clinically-validated mental health tools.

“When you live alone – you have to find other ways to do things to not be lonely or bored. It is so awesome. I really like it. When I have things on my mind the journaling is very helpful. I like to watch Socks make things float away or put things in the box. It is very intense. Keeps your mind thinking.” - F,46, Bipolar I disorder, moderate

“Everybody should start downloading Litesprite, it’s life changing.” – M, 40, Anxiety/Depression

We are realizing our vision of building a series of digital therapeutic purpose-driven games that mitigate a range of chronic conditions starting with mental health, then cancer and diabetes. Our trusted self-care tools and unique patient data were changing care even before COVID-19, and have proved more valuable since.

Our technology scales care delivery and can produce analytical and predictive insights. Providing reimbursable, empathetic, and inspiring self-care tools for patients that provide timely health status remotely to medical professionals will be even more paramount. This will be a foundation of new healthcare delivery models during and after COVID-19. We are already defining this future. Join us and participate to accelerate our progress! Thank you for your support!

Supporters

• 
  Hanna Norén
  06/15/2020 - Followed the project.
• 
  Hanna Norén
  06/15/2020 - Liked the project.
• 
  Mr. Patrick Hurd
  06/11/2020 - Followed the project.
• 
  Megan McNally
  06/11/2020 - Liked the project.
• 
  John Haine
  06/11/2020 - Followed the project.
• 
  John Haine
  06/11/2020 - Liked the project.
• 
  Priyanka Raha
  06/08/2020 - Liked the project.
• 
  Priyanka Raha
  06/08/2020 - Followed the project.
• 
  Alex Fair, MS
  06/08/2020 - Liked the project.
• 
  Jo Burkholder
  06/08/2020 - Liked the project.
• 
  Alex Fair
  06/08/2020 - Liked the project.
• 
  Molly Angel
  06/08/2020 - Liked the project.
• 
  Molly Angel
  06/08/2020 - Followed the project.
• 
  William Miller
  05/23/2020 - Liked the project.
• 
  Rebecca Lovell
  05/21/2020 - Followed the project.
• 
  Rebecca Lovell
  05/21/2020 - Liked the project.
• 
  Sean Watson
  05/21/2020 - Liked the project.
• 
  Sean Watson
  05/21/2020 - Followed the project.
• 
  Ted Tanase
  05/21/2020 - Followed the project.
• 
  Mr. Patrick Hurd
  05/19/2020 - Liked the project.
• 
  Rahul Tiwari
  05/19/2020 - Followed the project.
• 
  Rahul Tiwari
  05/19/2020 - Liked the project.
• 
  Ms. Swatee Surve, MS Mechanical Engineering, MBA
  05/18/2020 - Followed the project.
• 
  Ms. Swatee Surve, MS Mechanical Engineering, MBA
  05/18/2020 - Liked the project.

Comments

Login to post your comment!
Click here to Login

Updates

No updates found .